FORME FRUSTE KERATOCONUS (FFK)
Clinical trials for FORME FRUSTE KERATOCONUS (FFK) explained in plain language.
Never miss a new study
Get alerted when new FORME FRUSTE KERATOCONUS (FFK) trials appear
Sign up with your email to follow new studies for FORME FRUSTE KERATOCONUS (FFK), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Light treatment aims to halt vision loss in down syndrome patients
Disease control Recruiting nowThis study is testing an experimental treatment called corneal crosslinking (CXL) for people with Down syndrome who also have conditions that cause the clear front part of the eye (cornea) to thin and bulge, leading to worsening vision. The treatment involves applying vitamin B2 …
Matched conditions: FORME FRUSTE KERATOCONUS (FFK)
Phase: PHASE3 • Sponsor: Woolfson Eye Institute • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
Shorter light treatment for blurry vision disease put to the test
Disease control Recruiting nowThis study is testing if a shorter 18-minute ultraviolet light treatment works as well as the standard 24-minute treatment to stop the progression of certain eye diseases that cause the clear front of the eye (cornea) to thin and bulge, leading to blurred vision. The treatment, c…
Matched conditions: FORME FRUSTE KERATOCONUS (FFK)
Phase: PHASE3 • Sponsor: Woolfson Eye Institute • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC